B

Bavarian Nordic
BAVA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
DKK14.31B
EV
DKK13.19B
Shares Outstanding
77.84M
Beta
1.20

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
DKK267.50
P/E 2025E
11.95x
P/Revenue 2025E
2.22x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Bavarian Nordic A/S

gainify

B

Bavarian Nordic A/S

BAVA

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-b...

Sector

Healthcare

Industry

Biotechnology

CEO

Chaplin, Paul

Employees

1,645

IPO Date

2000-01-03

Headquarters

Philip Heymans Alle 3, Hellerup, Capital Region of Denmark, 2900, Denmark

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.